News About: Pharm. Industry
Taejoon Pharm attended 89th RSNA ExhibitionTaejoon Pharm said that it attended the 89th Radiology Society of North America (RSNA) Exhibition in Chicago of the United States during November 30 to December 4, this year for...
|
Yupan C to promote as a leading Vitamin C brand.
Yuyu is going to keep Yupan C at a top brand in the vitamin C markets through their heavy public advertising promotion, and very recently prepared a campaign advertising message for Yupan C by headlining as "Sorry lem...
Dong-A Pharm's Stillen witnessing successful launching in market
Dong-A Pharm said that its own new anti-ulcerant drug Stillen derived from natural substances has shown brisk sales of 7.0 billion won since the first launching on December of last year, thanks to superior efficacy an...
Bayer, GSK to provide methods of distinguishing original Levitra from counterfeit drugs
Bayer and GSK, which have co-promoted Levitra (vardenafil HCl) for treatment of erectile dysfunction (ED) worldwide, are endeavoring to offer various methods of identifying their original drug from counterfeit drugs t...
Tripartite competition on COPD markets.
The business interests in the chronic obstructive pulmonary disease (COPD) therapy is surging up slowly to the market and very competitive by 3 big foreign drug corporations, AstraZeneca, GSK and Boehringer/Pfizer.
...
Industry must accept Clinical study is an industry notion.
"The clinical study itself is an industry" is a voice of stressing the concept on its importance in view of the industrial development points.
The expert opinions pointed out that the multinational clinical studi...
Korea Green Cross, and Jaseng oriental hospital to jointly develop natural new drugs
Korea Green Cross R&D Co., an affiliated company of Korea Green Cross Corporation said that it signed with Jaseng oriental hospital a strategic joint venture in the development of natural new drugs on December 10.
...
GSK to conduct multinational study for Avodart including Korea
GlaxoSmithKline is set to conduct its multinational clinical study to evaluate the efficacy of the concurrent therapy of dutasteride (brandname: Avodart) plus tamsulosin in patients with benigh prostatic hyperplasia.
...
Pharmaceutical sales success largely relying on stronghold wholesalers.
The pharmaceutical sales success might be largely depending on how to keep a stronghold wholesaler in each region with full consideration of its risk, which is particularly true to the foreign multinational drug corpo...
Conglomerates keenly interested in M&A of domestic pharmaceutical industries.
Most of the local conglomerates are keenly interested in the M&A of domestic drug companies in view of its competitiveness. In the public subscription for Hanil pharmaceutical company stakes, 2 to 3 domestic conglomer...
